Latest filing published 06 Mar 2012 for CANCERVAX CORP, €180k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Peter Johann across 2 companies, led by Cancervax Corp and Horizon Therapeutics Public Ltd Co. In total, 19 filings cover trades dated from 24 July 2006 to 2 March 2012.
On the market, this insider has only ever bought: 10 purchases, €9.8M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €364k.
Most recently, on 6 March 2012, the filings show a transaction worth €180k in Cancervax Corp. The last purchase on record was published on 4 August 2011, which is 5,559 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations